Hospira Logo (Cytarabine 01)
Cytarabine Injection, Solution
Product Images NDC 61703-319
5 FDA label images from Hospira, Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 61703-319). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Cytarabine Structural Formula (Cytarabine 02)
Chemical structure diagram of Cytarabine showing the molecular formula C9H13N3O5 and molecular weight 243.22.*
Hospira Logo (Cytarabine 03)
Principal Display Panel (20 mL Vial Label)
Label of Cytarabine Injection 2 g/20 mL (100 mg/mL) sterile solution from Hospira Worldwide, Inc. The vial is a single-dose for intravenous, intrathecal, and subcutaneous use only. The label includes warnings about cytotoxicity, usage instructions, storage conditions, and regulatory information along with barcodes and the NDC 61703-319-22.*
Principal Display Panel (20 mL Vial Carton)
Packaging label for Cytarabine Injection 2 g/20 mL (100 mg/mL) single dose vial by Hospira Worldwide, Inc. The label indicates the vial is sterile and preservative free, for intravenous, intrathecal, and subcutaneous use only. It includes storage instructions and warnings, prominently marked as a cytotoxic agent.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
